✦ LIBER ✦

The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer

✍ Scribed by K Heimdal; L Mæhle; J Apold; J.C Pedersen; P Møller

Book ID: 117660173
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 218 KB
Volume: 39
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(03)00548-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High frequency and allele-specific diffe

High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus

✍ NV Bogdanova; NN Antonenkova; YI Rogov; JH Karstens; P Hillemanns; T Dörk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Recurrent BRCA1 and BRCA2 germline mutat

Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: A founder mutation of BRCA1 identified in the Chinese population

✍ Ui-Soon Khoo; Kelvin Y.K. Chan; Annie N.Y. Cheung; W.C. Xue; D.H. Shen; K.Y. Fun 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Previous mutational analysis for BRCA gene mutations in sporadic ovarian cancer occurring in Chinese patients in Hong Kong identified six germline BRCA1 mutations and one germline BRCA2 mutation, six of which were novel (Khoo et al., 2000). Knowledge of BRCA gene mutations in the Chinese population

The contribution of founder mutations in

The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania

✍ P Elsakov; J Kurtinaitis; S Petraitis; V Ostapenko; M Razumas; T Razumas; R Mesk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 510 KB

A founder mutation of the BRCA1 gene in

A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer

✍ Z Einbeigi; A Bergman; L.-G Kindblom; T Martinsson; J.M Meis-Kindblom; M Nordlin 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Tamoxifen and the risk of ovarian cancer

Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers

✍ Danielle Vicus; Barry Rosen; Jan Lubinski; Susan Domchek; Noah D. Kauff; Henry T 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 131 KB

The risk of primary and contralateral br

The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1 / BRCA2 mutation carriers

✍ Vencken, Peggy M. L. H.; Kriege, Mieke; Hooning, Maartje; Menke-Pluymers, Marian 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB